Literature DB >> 21151031

An audience with...Francis Collins. Interviewed by Asher Mullard.

Francis Collins.   

Abstract

Mesh：

Year:  2010        PMID： 21151031     DOI： 10.1038/nrd3357

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  10 in total

1.  The NIH translational research center might trade public risk for private reward.

Authors:  Jerry Avorn; Aaron S Kesselheim
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

2.  Medicinal chemistry for 2020.

Authors:  Seetharama D Satyanarayanajois; Ronald A Hill
Journal:  Future Med Chem       Date:  2011-10       Impact factor: 3.808

Review 3.  An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.

Authors:  Aaron S Kesselheim
Journal:  Milbank Q       Date:  2011-09       Impact factor: 4.911

4.  An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?

Authors:  Bruce H Littman
Journal:  Nat Rev Drug Discov       Date:  2011-05-20       Impact factor: 84.694

5.  Connecting the dots in translational research.

Authors:  Jonathan D Kahn
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

6.  Teach-Discover-Treat (TDT): collaborative computational drug discovery for neglected diseases.

Authors:  Johanna M Jansen; Wendy Cornell; Y Jane Tseng; Rommie E Amaro
Journal:  J Mol Graph Model       Date:  2012-08-30       Impact factor: 2.518

Review 7.  Lost but making progress--Where will new analgesic drugs come from?

Authors:  David Borsook; Richard Hargreaves; Chas Bountra; Frank Porreca
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

8.  Rare diseases research: expanding collaborative translational research opportunities.

Authors:  Stephen C Groft
Journal:  Chest       Date:  2013-07       Impact factor: 9.410

9.  The prevalence and cost of unapproved uses of top-selling orphan drugs.

Authors:  Aaron S Kesselheim; Jessica A Myers; Daniel H Solomon; Wolfgang C Winkelmayer; Raisa Levin; Jerry Avorn
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

Review 10.  High throughput screening in duchenne muscular dystrophy: from drug discovery to functional genomics.

Authors:  Thomas J J Gintjee; Alvin S H Magh; Carmen Bertoni
Journal:  Biology (Basel)       Date:  2014-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.